University of Thessaly | Greece
Dr Braliou is a scientist specializing in Molecular Biology, Biochemistry, and Genetic Epidemiology. She obtained her academic training in Chemistry and later completed her PhD in Molecular Biology and Biochemistry through research conducted at leading European institutions, including the European Molecular Biology Laboratory and Radboud University Nijmegen. Her research primarily focuses on gene regulation mechanisms, including transcriptional control by nuclear receptors, cis-regulatory DNA elements, and epigenetic modifications. She has also contributed to understanding the regulation of hepcidin by hypoxia-induced factors during her postdoctoral work at the University of Thessaly. Expanding into computational biology and bioinformatics, her work integrates genetic epidemiology approaches, particularly in analyzing SNPs, gene expression, and GWAS data using statistical and computational methods.
Citation Metrics (Scopus)
View Scopus Profile
View Google Scholar Profile
View Orcid Profile
View Scilit Profile
View SciProfiles Profile
Featured Publications
Featured Publications
Antibody tests in detecting SARS-COV-2 infection: a meta-analysis
Diagnostics
– 2020 — Cited by 334
Transport of hypoxia-inducible factor HIF-1α into the nucleus involves importins 4 and 7
Biochemical and Biophysical Research Communications
– 2009 — Cited by 127
2-Oxoglutarate-dependent oxygenases control hepcidin gene expression
– Journal of Hepatology, 2008 — Cited by 98
Antioxidant Activity of Leaf Extracts from Stevia rebaudiana Bertoni: A Systematic Review and Meta-Analysis
–Nutrients, 2023 — Cited by 505
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo
– The EMBO Journal, 1998 — Cited by 41